Valuation: FONAR Corporation

Market Cap 125M 107M 100M 91.73M 173M 11.92B 175M 1.18B 461M 6.02B 470M 459M 19.92B P/E 2024
10.3x
P/E 2025 11.9x
Enterprise Value 108M 92.15M 86.34M 78.87M 149M 10.25B 150M 1.02B 396M 5.17B 404M 395M 17.13B EV / Sales 2024
0.9x
EV / Sales 2025 0.77x
Free-Float
76.43%
Yield 2024 *
-
Yield 2025 -
1 day-0.10%
3 months+1.03%
6 months+2.74%
Current year+2.86%
Current year 18.3
Extreme 18.3
19.16
1 year 13.9
Extreme 13.9
19.16
3 years 12
Extreme 12
24.05
5 years 12
Extreme 12
24.05
10 years 11
Extreme 11
33.9
Manager TitleAgeSince
Chief Executive Officer 61 2016-02-10
Director of Finance/CFO 71 2022-08-31
Investor Relations Contact - 1978-05-31
Director TitleAgeSince
Chairman 61 2022-09-06
Date Insider Type Main position Quantity % Market Cap.
9/29/22 Buy

Chief Financial Officer

4,700 0.0717%
9/29/22 Buy

Chief Executive Officer

4,700 0.0717%
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%-.--%+24.04%+16.40% 125M
+0.64%+3.06%+29.45%+15.98% 232B
-0.18%+1.94%+4.54%-17.55% 152B
-0.79%-7.42%-22.36%+22.13% 131B
-4.38%-8.34%-55.19%-11.38% 72.26B
-0.64%-1.25%-16.43%-13.70% 51.57B
+0.37%-1.44%+11.91%+19.62% 52.38B
-0.84%-1.58%+29.30%+27.55% 43.71B
+0.31%+0.13%+40.61%+47.95% 40.72B
+0.17%+10.04%+128.48%+42.59% 33.97B
Average -0.55%+3.60%+17.43%+14.96% 81.02B
Weighted average by Cap. -0.41%+3.71%+9.48%+9.95%

Financials

2024 2025
Net sales 103M 88.16M 82.61M 75.46M 142M 9.81B 144M 974M 379M 4.95B 386M 378M 16.39B 104M 89.42M 83.79M 76.53M 144M 9.95B 146M 988M 385M 5.02B 392M 383M 16.62B
Net income 10.57M 9.06M 8.48M 7.75M 14.63M 1.01B 14.77M 100M 38.96M 508M 39.68M 38.81M 1.68B 8.33M 7.14M 6.69M 6.11M 11.54M 795M 11.65M 78.93M 30.73M 401M 31.29M 30.61M 1.33B
Net Debt -14.8M -12.68M -11.88M -10.86M -20.49M -1.41B -20.69M -140M -54.57M -712M -55.58M -54.37M -2.36B -17.54M -15.03M -14.08M -12.86M -24.27M -1.67B -24.51M -166M -64.65M -843M -65.84M -64.41M -2.79B
Logo FONAR Corporation
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, hiring, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Employees
535
  1. Stock Market
  2. Stocks
  3. FONR Stock